Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Adamson

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Cancer Chemotherapy and Pharmacology|July 25, 2003
Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancerPatrick Thompson, Frank Balis, Baruti M Serabe, et al.
Immunobiology|August 27, 2015
Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in miceTamar R Grossman, Lisa A Hettrick, Robert B Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2017
Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group StudyYael P Mossé, Stephan D Voss, Megan S Lim, et al.
Investigative Ophthalmology & Visual Science|January 31, 2002
Characterization of genetically modified human retinal pigment epithelial cells developed for in vitro and transplantation studiesNaheed Kanuga, Helen L Winton, Laurence Beauchéne, et al.
Investigative Ophthalmology & Visual Science|May 22, 2014
Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunctionNorihiro Nagai, Pete Lundh von Leithner, Kanako Izumi-Nagai, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administrationThomas J Walsh, Mats O Karlsson, Timothy Driscoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitisSusan M Blaney, Richard Heideman, Stacey Berg, et al.
The American Journal of Pathology|July 19, 2015
Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular PermeabilityNori Nagai, Meihua Ju, Kanako Izumi-Nagai, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2016
Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetesPaul Canning, Bridget-Ann Kenny, Vivien Prise, et al.
Investigative Ophthalmology & Visual Science|August 19, 2015
IL-18 Immunotherapy for Neovascular AMD: Tolerability and Efficacy in Nonhuman PrimatesSarah L Doyle, Francisco J López, Lucia Celkova, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Cancer Chemotherapy and Pharmacology|July 25, 2003
Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancerPatrick Thompson, Frank Balis, Baruti M Serabe, et al.
Immunobiology|August 27, 2015
Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in miceTamar R Grossman, Lisa A Hettrick, Robert B Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2017
Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group StudyYael P Mossé, Stephan D Voss, Megan S Lim, et al.
Investigative Ophthalmology & Visual Science|January 31, 2002
Characterization of genetically modified human retinal pigment epithelial cells developed for in vitro and transplantation studiesNaheed Kanuga, Helen L Winton, Laurence Beauchéne, et al.
Investigative Ophthalmology & Visual Science|May 22, 2014
Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunctionNorihiro Nagai, Pete Lundh von Leithner, Kanako Izumi-Nagai, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administrationThomas J Walsh, Mats O Karlsson, Timothy Driscoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitisSusan M Blaney, Richard Heideman, Stacey Berg, et al.
The American Journal of Pathology|July 19, 2015
Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular PermeabilityNori Nagai, Meihua Ju, Kanako Izumi-Nagai, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2016
Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetesPaul Canning, Bridget-Ann Kenny, Vivien Prise, et al.
Investigative Ophthalmology & Visual Science|August 19, 2015
IL-18 Immunotherapy for Neovascular AMD: Tolerability and Efficacy in Nonhuman PrimatesSarah L Doyle, Francisco J López, Lucia Celkova, et al.
Pageof 8